APA (7th ed.) Citation

LH, C., PH, T., YF, C., CL, Y., TC, T., & YF, F. (2026). Real-World Safety and Retention of Tofacitinib in Elderly Versus Non-elderly Patients With Rheumatoid Arthritis: A Retrospective Cohort Study in Taiwan. International journal of rheumatic diseases, 29(5), e70683. https://doi.org/10.1111/1756-185x.70683

Chicago Style (17th ed.) Citation

LH, Chiang, Tsai PH, Chen YF, Yu CL, Tsai TC, and Fang YF. "Real-World Safety and Retention of Tofacitinib in Elderly Versus Non-elderly Patients With Rheumatoid Arthritis: A Retrospective Cohort Study in Taiwan." International Journal of Rheumatic Diseases 29, no. 5 (2026): e70683. https://doi.org/10.1111/1756-185x.70683.

MLA (9th ed.) Citation

LH, Chiang, et al. "Real-World Safety and Retention of Tofacitinib in Elderly Versus Non-elderly Patients With Rheumatoid Arthritis: A Retrospective Cohort Study in Taiwan." International Journal of Rheumatic Diseases, vol. 29, no. 5, 2026, p. e70683, https://doi.org/10.1111/1756-185x.70683.